Neogen Chemicals Limited has filed a disclosure regarding compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The filing details the sale of 2,361 equity shares by Sanjay Natwarlal Mehta HUF, an entity associated with a director of a wholly-owned subsidiary. The transactions, representing 0.01% of the company’s paid-up capital, occurred on November 5 and 6, 2026.
Disclosure of Share Transactions
Neogen Chemicals Limited has submitted a disclosure to the BSE Limited and the National Stock Exchange of India Limited concerning the sale of equity shares by Sanjay Natwarlal Mehta HUF. This disclosure is made pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Transaction Details
Sanjay Natwarlal Mehta HUF, identified as an entity associated with a director of a wholly-owned subsidiary of Neogen Chemicals, sold a total of 2,361 equity shares. These sales occurred on the stock exchange on November 5, 2026, and November 6, 2026. The shares sold represent approximately 0.01% of the company’s total paid-up capital. The total consideration for these sales amounted to ₹1,47,973.80 on November 5, 2026, and ₹57,08,127 on November 6, 2026.
Compliance Confirmation
The disclosure confirms that the transactions were conducted in compliance with the applicable regulations. The attached Annexure 3 provides a detailed breakdown of the transactions, including the number of securities, the nature of the transaction (sale), and the consideration received.
The company has also enclosed Form C, a continual disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015, detailing the change in holding of securities. This form reiterates the sale of 61 equity shares on November 5, 2026, and 2,300 equity shares on November 6, 2026, by Sanjay Natwarlal Mehta HUF, through the stock exchange on NSE. The combined holding post-transaction is noted as 6700 equity shares, representing approximately 0.02% of the company’s share capital.
Source: BSE
